Public Company News

Qifu Technology Won the Title of "MOST HONORED COMPANY" for the Second Consecutive Year

SHANGHAI, May 27, 2025 /PRNewswire/ -- Recently, Qifu Technology (Nasdaq: QFIN; Hong Kong Stock Exchange: 3660), a leading Chinese fintech company, has secured the title of "Most Honored Company" in the 2025 Extel Asia (ex-Japan) Best Managed Teams rankings, a global leader in corporate governanc...

2025-05-27 14:19 3580

Tuniu to Report First Quarter 2025 Financial Results on June 12, 2025

NANJING, China, May 27, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it plans to release its unaudited financial results for the first quarter endedMarch 31, 2025, before the market opens on ...

2025-05-27 14:00 3579

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval inIndonesia. This marks the ZYLOX Unicorn™ Vascular Cl...

2025-05-27 10:14 3734

Pony.ai Partners with Dubai RTA to Accelerate Autonomous Mobility in the Middle Eastern Metropolis

DUBAI, UAE, May 26, 2025 /PRNewswire/ -- Pony.ai (NASDAQ: PONY) today announces that it has entered a Memorandum of Understanding (MoU) with Dubai's Roads and Transport Authority (RTA) to deploy its advanced robotaxi fleet in the region. The collaboration underscores Pony.ai's commitment to advan...

2025-05-27 10:00 2440

Pro Anime AI Video Generation Platform Animon.ai Launches in Korea

Key technology upgrades accompany market entry, providing an even better user experience TOKYO and SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") today announced market entry in Korea and significant updates to its groundbreaking AI anime video g...

2025-05-27 09:00 4386

RBW Signs Strategic Partnership with NetEase Cloud Music to Expand K-POP's Global Reach Among Chinese Youth

HANGZHOU, China, May 26, 2025 /PRNewswire/ -- RBW Inc. (KOSDAQ: 361570), a leading integrated content production company and home to top K-POP acts such as MAMAMOO, ONEUS, ONEWE, and PURPLE KISS, has entered into a strategic copyright partnership with NetEase Cloud Music (HKEX: 9899), one ofChina...

2025-05-26 22:00 4087

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) ...

2025-05-26 21:00 2567

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with ORR of 84.2% * DZD6008, a BBB-penetrant 4th generation EGFR TKI, showed encouraging and durable anti-tumor activity with favorable safet...

2025-05-26 18:06 2451

Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...

2025-05-24 01:47 4512

/DISREGARD RELEASE: Celltrion/

We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...

2025-05-24 00:01 4527

Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...

2025-05-23 22:00 4488

WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

LANGFANG, China, May 23, 2025 /PRNewswire/ -- From May 19 to 23, 2025, the 29th World Gas Conference (WGC2025), hosted by the International Gas Union (IGU), convened inBeijing. As the premier global event in the energy sector, WGC2025 attracted leading companies and industry experts from around t...

2025-05-23 20:00 4182

Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

HONG KONG, May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:DXF

2025-05-23 18:30 5710

Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq

NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market L...

2025-05-23 17:00 4611

MINISO Group Announces March Quarter 2025 Unaudited Financial Results

Revenue grew 18.9 % year over year Significant sequential improvement of same-store sales(1) in MINISO mainland China for March Quarter Gross margin reached 44.2%, up 0.8 ppt year over year Adjusted EBITDA increased 7.5% year over year to RMB1,037.3 million Shareholder returns reached around RM...

2025-05-23 16:33 8128

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, to...

2025-05-23 10:44 2514

CARsgen's Satri-cel Abstract Available on ASCO Website

SHANGHAI, May 22, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that an abstract of the research results of the confirmatory Phase II clinical trial of satricabtagene autoleucel ("satri-...

2025-05-23 08:00 2389

China Liberal Education Holdings Limited Receives Additional Nasdaq Staff Determination Letter of Delinquency

BEIJING, May 22, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that on May 21, 2025, ...

2025-05-23 04:05 2379

Innodisk Showcased Embedded and Automation Innovations at Automate Show 2025

DETROIT, May 22, 2025 /PRNewswire/ -- Innodisk, a global leader in edge AI solutions, showcased its latest embedded and automation technologies at the Automate Show 2025, recently held in Detroit. With a sharp focus on advancing AI innovation for industrial applications, Innodisk bridges AI concep...

2025-05-23 00:00 3635

Yunji Selects WWC, P.C. as its Independent Registered Public Accounting Firm

HANGZHOU, China, May 22, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that the Company's board of directors and the audit committee of the board approved the dismissal of PricewaterhouseCoopers Zhon...

2025-05-22 20:30 4299
1 ... 107108109110111112113 ... 772